China · Delayed Price · Currency is CNY BeBetter Med Statistics
Total Valuation
BeBetter Med has a market cap or net worth of CNY 18.15 billion. The enterprise value is 18.02 billion.
| Market Cap | 18.15B |
| Enterprise Value | 18.02B |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BeBetter Med has 450.04 million shares outstanding.
| Current Share Class | 450.04M |
| Shares Outstanding | 450.04M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +5.42% |
| Owned by Insiders (%) | 50.03% |
| Owned by Institutions (%) | 18.55% |
| Float | 178.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 62.52 |
| P/TBV Ratio | 72.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -321.88 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -166.06 |
Financial Position
The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.07 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -22.03% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BeBetter Med has paid 90,482 in taxes.
| Income Tax | 90,482 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 40.31 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.85 |
| Average Volume (20 Days) | 4,178,941 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -65.05M |
| Pretax Income | -55.91M |
| Net Income | -56.00M |
| EBITDA | -57.71M |
| EBIT | -65.05M |
| Earnings Per Share (EPS) | -0.16 |
Balance Sheet
The company has 163.83 million in cash and 5.84 million in debt, with a net cash position of 157.99 million or 0.35 per share.
| Cash & Cash Equivalents | 163.83M |
| Total Debt | 5.84M |
| Net Cash | 157.99M |
| Net Cash Per Share | 0.35 |
| Equity (Book Value) | 290.22M |
| Book Value Per Share | 0.83 |
| Working Capital | 188.83M |
Cash Flow
In the last 12 months, operating cash flow was -89.61 million and capital expenditures -18.93 million, giving a free cash flow of -108.54 million.
| Operating Cash Flow | -89.61M |
| Capital Expenditures | -18.93M |
| Free Cash Flow | -108.54M |
| FCF Per Share | -0.24 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BeBetter Med does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.31% |
| FCF Yield | -0.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |